vTv Therapeutics Inc.
VTVT
$33.28
-$0.43-1.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -44.33% | 71.09% | |||
| Gross Profit | 44.33% | -71.09% | |||
| SG&A Expenses | 8.10% | 1.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.30% | 38.57% | |||
| Operating Income | 26.30% | -38.57% | |||
| Income Before Tax | 31.00% | -40.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 31.00% | -40.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -100.00% | 23.46% | |||
| Net Income | 17.94% | -43.86% | |||
| EBIT | 26.30% | -38.57% | |||
| EBITDA | 26.31% | -38.60% | |||
| EPS Basic | 46.91% | -17.63% | |||
| Normalized Basic EPS | 40.09% | -20.17% | |||
| EPS Diluted | 46.91% | -17.63% | |||
| Normalized Diluted EPS | 40.09% | -20.17% | |||
| Average Basic Shares Outstanding | 54.58% | 22.30% | |||
| Average Diluted Shares Outstanding | 54.58% | 22.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||